Analyst Calls: Three top picks for a 22-37% upside
indiatimes.com
economics
2022-10-19 02:15:00

iStockThe brokerage has raised its price target on Craftsman to Rs 3,800 from Rs 3,600 while maintaining its buy rating. ET looks at some of the stock recommendations by analysts of late. These stocks are expected to return between 22% and 37% as per analysts' price targets. 
GLAND PHARMABrokerage: Morgan Stanley
Price Target: Rs 2,748
CMP: Rs 2,155
Upside: 27.5% Morgan Stanley has initiated coverage on Gland with an overweight rating. 'Our rating is driven by Gland's entrenched presence in a difficult injectable category; its capital-efficient business model, our forecast for a 22% EPS CAGR for F23-24; a strong balance sheet; and its sharp 45% YTD stock price correction,' said the brokerage in a client note.
